Login / Signup

Psychotropic medication use in people living with severe and persistent mental illness in the Australian community: a cross-sectional study.

Jie HuSara Sinclair McMillanTheo TheodorosJack Charles CollinsSarira El-DenClaire L O'reillyAmanda J Wheeler
Published in: BMC psychiatry (2022)
Psychotropic polypharmacy was common in this community cohort experiencing SPMI. Whilst polypharmacy is not always inappropriate, it is a complex construct with potential benefits alongside potential risks. Benefits and harms need to be balanced however this practice is not supported by clear guidance to assist health practitioners. This study highlights the important need for regular medication reviews and strengthened communication between consumers and all healthcare professionals involved in community mental health care, to support safe and effective use of psychotropic medications.
Keyphrases